A 58-year-old man with a history of tuberculosis treated with isoniazid and rifampin for 6 months presents with a new-onset seizure. He also reports peripheral neuropathy developing during TB treatment that never fully resolved. Current medications include only a multivitamin. Neurological examination confirms distal sensory loss and absent ankle reflexes. EEG shows focal epileptiform activity. MRI brain is unremarkable. Laboratory studies including glucose, electrolytes, and kidney function are normal. Considering his medication history and current presentation, which biochemical mechanism best explains the relationship between his previous treatment and current neurological manifestations?
Q2
A 4-year-old child presents with bowing of the legs, swelling at the wrists and ankles, and frontal bossing. The family recently immigrated from a country with limited sunlight exposure and maintains a strict vegan diet with no supplementation. X-rays show widened metaphyses and cupping of the epiphyses. Laboratory studies show low serum calcium (7.5 mg/dL), low phosphate (2.8 mg/dL), and elevated alkaline phosphatase (450 U/L). Apply the biochemical principles to identify which enzyme's activity is most critically impaired in this child's bone pathology.
Q3
A 35-year-old woman with epilepsy controlled on phenytoin for 10 years presents during her first prenatal visit at 8 weeks gestation. She reports she stopped taking folic acid supplements 3 months ago due to nausea. Her sister had a child with spina bifida. Laboratory studies show hemoglobin 11.8 g/dL with MCV 101 fL and elevated homocysteine. Neural tube defect screening shows elevated alpha-fetoprotein. Considering the timing of presentation, medication history, and family history, evaluate the optimal management strategy.
Q4
A 42-year-old man with chronic pancreatitis and steatorrhea presents with bone pain and recent fractures after minor trauma. Radiographs show decreased bone density and pseudofractures. Laboratory studies reveal low serum calcium (7.8 mg/dL), elevated parathyroid hormone, elevated alkaline phosphatase, low 25-hydroxyvitamin D, but surprisingly normal 1,25-dihydroxyvitamin D levels. He has been taking oral vitamin D supplements as prescribed. Synthesize the biochemical and physiological factors to explain this paradoxical laboratory pattern.
Q5
A 6-month-old infant born prematurely at 28 weeks gestation is brought to the pediatrician for a well-child visit. The infant has been exclusively formula-fed with a standard cow's milk-based formula. Physical examination reveals pallor, irritability, and mild jaundice. Laboratory studies show hemoglobin 8.5 g/dL, elevated indirect bilirubin, and decreased haptoglobin. Peripheral blood smear shows fragmented red blood cells and acanthocytes. The infant's creatine kinase is also elevated. Apply your understanding of neonatal biochemistry to determine the most appropriate initial intervention.
Q6
A 28-year-old woman presents with easy bruising and prolonged bleeding after minor cuts. She reports following a strict fat-free diet for weight loss over the past 6 months. Laboratory studies show prolonged prothrombin time (PT) and normal activated partial thromboplastin time (aPTT). Administration of a specific vitamin corrects the PT within hours. However, the patient also complains of night blindness that does not improve with the same vitamin supplementation. Evaluate the most likely explanation for this clinical scenario.
Q7
A 55-year-old woman with Crohn disease on long-term sulfasalazine therapy presents with fatigue and glossitis. Laboratory studies show hemoglobin 10.1 g/dL with MCV 103 fL and elevated homocysteine levels, but normal methylmalonic acid levels. Peripheral smear shows hypersegmented neutrophils. Despite these findings suggesting a specific vitamin deficiency, her neural tube defect screening during a previous pregnancy 25 years ago showed elevated alpha-fetoprotein. Considering her current medication and disease history, which biochemical pathway is most directly impaired?
Q8
A 3-year-old child is brought to the clinic by his mother who reports that he refuses to walk and cries when his legs are touched. Physical examination reveals tenderness over the lower extremities, particularly at the metaphyses of long bones. The child has a protruding abdomen and prominent costochondral junctions. His gums are swollen and bleeding. Dietary history reveals that the family follows a restrictive diet excluding fruits and vegetables. Laboratory studies show normal calcium and phosphate levels. What enzyme deficiency best explains this patient's presentation?
Q9
A 62-year-old man with a history of gastric bypass surgery 5 years ago presents with progressive weakness, paresthesias in his lower extremities, and difficulty with balance. Physical examination reveals decreased vibration and proprioception in the legs, absent ankle reflexes, and a positive Romberg sign. Complete blood count shows hemoglobin 9.2 g/dL with MCV 112 fL. Peripheral blood smear shows hypersegmented neutrophils. What is the underlying biochemical mechanism of his neurological symptoms?
Q10
A 45-year-old chronic alcoholic presents to the emergency department with confusion, ataxia, and ophthalmoplegia. His wife reports he has been drinking heavily for the past 3 months and eating very little. Vital signs show blood pressure 130/85 mmHg, heart rate 98/min, and temperature 37.2°C. Before administering intravenous dextrose for suspected hypoglycemia, which intervention is most appropriate to prevent worsening of his neurological condition?
Vitamin/mineral functions and deficiencies US Medical PG Practice Questions and MCQs
Question 1: A 58-year-old man with a history of tuberculosis treated with isoniazid and rifampin for 6 months presents with a new-onset seizure. He also reports peripheral neuropathy developing during TB treatment that never fully resolved. Current medications include only a multivitamin. Neurological examination confirms distal sensory loss and absent ankle reflexes. EEG shows focal epileptiform activity. MRI brain is unremarkable. Laboratory studies including glucose, electrolytes, and kidney function are normal. Considering his medication history and current presentation, which biochemical mechanism best explains the relationship between his previous treatment and current neurological manifestations?
A. Mycobacterium tuberculosis producing neurotoxins causing delayed neurological sequelae
B. Isoniazid-induced depletion of pyridoxine cofactor impairing GABA synthesis and causing excitotoxicity (Correct Answer)
C. Immune reconstitution inflammatory syndrome affecting the central nervous system
D. Rifampin-induced hepatic enzyme induction causing accelerated metabolism of endogenous neuroprotective factors
E. Combined drug toxicity causing direct neuronal damage independent of vitamin metabolism
Explanation: ***Isoniazid-induced depletion of pyridoxine cofactor impairing GABA synthesis and causing excitotoxicity***
- **Isoniazid** structurally resembles **pyridoxine (vitamin B6)** and competitively inhibits **pyridoxine kinase**, leading to a functional deficiency of **pyridoxal-5-phosphate (PLP)**.
- **PLP** is a vital cofactor for **glutamic acid decarboxylase (GAD)**, which converts glutamate to **GABA**; a lack of this inhibitory neurotransmitter results in **central nervous system hyperexcitability** (seizures) and **peripheral neuropathy**.
*Rifampin-induced hepatic enzyme induction causing accelerated metabolism of endogenous neuroprotective factors*
- Although **rifampin** is a potent inducer of the **cytochrome P450** system, it does not significantly accelerate the degradation of **pyridoxine** or other neuroprotective factors to the point of causing seizures.
- This mechanism is more clinically relevant for **drug-drug interactions** (e.g., reducing the efficacy of oral contraceptives) rather than direct **neurotoxicity**.
*Combined drug toxicity causing direct neuronal damage independent of vitamin metabolism*
- **Isoniazid** toxicity is specifically linked to **vitamin B6 metabolism**; symptoms are typically reversible or preventable with pyridoxine supplementation.
- There is no evidence that isoniazid and rifampin act as direct **neurotoxins** to axons or neurons in a way that bypasses **biochemical cofactor** pathways.
*Immune reconstitution inflammatory syndrome affecting the central nervous system*
- **IRIS** typically occurs shortly after starting treatment for TB or HIV when the immune system recovers and attacks **residual antigens**, often presenting with worsening infectious symptoms.
- Since the patient's MRI is **unremarkable** and he has completed treatment, a late-stage inflammatory response is unlikely compared to the known **isoniazid-B6 interaction**.
*Mycobacterium tuberculosis producing neurotoxins causing delayed neurological sequelae*
- **Mycobacterium tuberculosis** does not produce potent exotoxins or **neurotoxins** that trigger delayed neurological disorders or seizures long after treatment.
- Neurological sequelae from TB are generally due to **direct infection** (tubercular meningitis or tuberculomas), which would typically be visible on a **brain MRI**.
Question 2: A 4-year-old child presents with bowing of the legs, swelling at the wrists and ankles, and frontal bossing. The family recently immigrated from a country with limited sunlight exposure and maintains a strict vegan diet with no supplementation. X-rays show widened metaphyses and cupping of the epiphyses. Laboratory studies show low serum calcium (7.5 mg/dL), low phosphate (2.8 mg/dL), and elevated alkaline phosphatase (450 U/L). Apply the biochemical principles to identify which enzyme's activity is most critically impaired in this child's bone pathology.
A. Gamma-glutamyl carboxylase affecting osteocalcin function
B. 25-hydroxylase in the liver preventing adequate vitamin D activation
C. Lysyl oxidase causing defective collagen cross-linking in bone matrix
D. 1-alpha-hydroxylase in the kidney reducing calcitriol production (Correct Answer)
E. Alkaline phosphatase in osteoblasts impairing bone mineralization
Explanation: ***1-alpha-hydroxylase in the kidney reducing calcitriol production***
- This enzyme, located in the **proximal renal tubules**, catalyzes the final step of **Vitamin D activation**; its failure to produce **1,25-(OH)₂D (calcitriol)** leads to the classic findings of **Rickets**.
- Low levels of **calcitriol** result in decreased intestinal **calcium and phosphate absorption**, leading to the biochemical profile of hypocalcemia and skeletal deformities like **frontal bossing** and **bowing of legs**.
*25-hydroxylase in the liver preventing adequate vitamin D activation*
- While this enzyme performs the first step of activation, the pathology in dietary/sunlight deficiency is due to a lack of **Vitamin D3 (cholecalciferol)** substrate rather than intrinsic enzyme impairment.
- Impairment of this enzyme is rare and usually associated with severe **chronic liver disease**, which is not indicated in this child's history.
*Alkaline phosphatase in osteoblasts impairing bone mineralization*
- In Rickets, **Alkaline Phosphatase (ALP)** activity is actually **elevated** (450 U/L in this case) as osteoblasts attempt to compensate for the mineralization defect.
- Impaired ALP activity is seen in **hypophosphatasia**, a rare genetic disorder, not in nutritional Vitamin D deficiency.
*Lysyl oxidase causing defective collagen cross-linking in bone matrix*
- **Lysyl oxidase** is a copper-dependent enzyme; its impairment leads to conditions like **Menkes disease** or **Lathyrism**, focusing on connective tissue laxity.
- While it affects bone matrix integrity, it does not produce the specific **biochemical abnormalities** (low calcium/phosphate) or **metaphyseal cupping** seen here.
*Gamma-glutamyl carboxylase affecting osteocalcin function*
- This enzyme requires **Vitamin K** to carboxylate **osteocalcin**, which is necessary for binding calcium to the bone hydroxyapatite matrix.
- Deficiency primarily affects **blood coagulation** and does not lead to the high **Alkaline Phosphatase** or the skeletal radiographic changes characteristic of Vitamin D deficiency.
Question 3: A 35-year-old woman with epilepsy controlled on phenytoin for 10 years presents during her first prenatal visit at 8 weeks gestation. She reports she stopped taking folic acid supplements 3 months ago due to nausea. Her sister had a child with spina bifida. Laboratory studies show hemoglobin 11.8 g/dL with MCV 101 fL and elevated homocysteine. Neural tube defect screening shows elevated alpha-fetoprotein. Considering the timing of presentation, medication history, and family history, evaluate the optimal management strategy.
A. Switch to newer antiepileptic drug and defer folate supplementation until second trimester
B. Immediate high-dose folate supplementation and continue phenytoin with close monitoring
C. High-dose folate supplementation with recommendation for detailed fetal ultrasound and possible termination counseling (Correct Answer)
D. Discontinue phenytoin immediately and start alternative antiepileptic with folate supplementation
E. Continue current regimen as neural tube defects are already determined by this gestational age
Explanation: ***High-dose folate supplementation with recommendation for detailed fetal ultrasound and possible termination counseling***
- The **neural tube** normally closes by **6 weeks gestation** (28 days post-conception); therefore, the primary window for preventing **neural tube defects (NTDs)** with folic acid has already passed for this pregnancy.
- Given the **elevated alpha-fetoprotein (AFP)**, macrocytosis, and positive **family history**, the fetus is at extreme risk; management must focus on diagnostic **ultrasound** and counseling regarding fetal anomalies already present.
*Immediate high-dose folate supplementation and continue phenytoin with close monitoring*
- While **high-dose folate (4 mg)** is indicated for subsequent risks and maternal health, it cannot reverse an **NTD** that has already occurred by week 8.
- Continuing **Phenytoin** is generally advised to prevent seizures, but this option fails to address the diagnostic implications of the **elevated AFP** already reported.
*Discontinue phenytoin immediately and start alternative antiepileptic with folate supplementation*
- Abruptly discontinuing **phenytoin** poses a severe risk of **status epilepticus**, which can cause fetal hypoxia and maternal morbidity.
- Switching anti-epileptic drugs (AEDs) during the **first trimester** is usually avoided if the patient is stable, as the period of **organogenesis** is already well underway or completed for many structures.
*Continue current regimen as neural tube defects are already determined by this gestational age*
- This approach is partially correct regarding the timing of **morphogenesis**, but it neglects the clinical significance of the **elevated AFP** and the need for maternal supplementation.
- Failing to offer **detailed imaging** or counseling following an abnormal screening test (AFP) deviates from standard **obstetric care**.
*Switch to newer antiepileptic drug and defer folate supplementation until second trimester*
- Deferring **folate** to the second trimester is contraindicated, as folate is still required for **maternal erythropoiesis** and to address the patient's existing **macrocytic anemia**.
- Introducing a new **AED** at this stage introduces unknown variables regarding **seizure control** and potential toxicity without fixing the damage already indicated by the screen.
Question 4: A 42-year-old man with chronic pancreatitis and steatorrhea presents with bone pain and recent fractures after minor trauma. Radiographs show decreased bone density and pseudofractures. Laboratory studies reveal low serum calcium (7.8 mg/dL), elevated parathyroid hormone, elevated alkaline phosphatase, low 25-hydroxyvitamin D, but surprisingly normal 1,25-dihydroxyvitamin D levels. He has been taking oral vitamin D supplements as prescribed. Synthesize the biochemical and physiological factors to explain this paradoxical laboratory pattern.
A. Chronic kidney disease causing impaired vitamin D metabolism despite normal creatinine
B. Adequate 1-alpha-hydroxylase activity in kidneys compensating for low substrate availability despite poor intestinal absorption (Correct Answer)
C. Adequate sun exposure providing sufficient cutaneous vitamin D synthesis independent of oral supplementation
D. Laboratory error in measurement of 1,25-dihydroxyvitamin D requiring repeat testing
E. Primary hyperparathyroidism causing increased conversion of 25-hydroxyvitamin D to active form
Explanation: ***Adequate 1-alpha-hydroxylase activity in kidneys compensating for low substrate availability despite poor intestinal absorption***
- Chronic **steatorrhea** leads to malabsorption of fat-soluble **vitamin D**, causing low **25-hydroxyvitamin D** stores, but elevated **PTH** acts as a potent stimulator of renal conversion.
- The **1-alpha-hydroxylase** enzyme is upregulated to synthesize **1,25-dihydroxyvitamin D** at near-normal rates even when the precursor is scarce, a classic finding in early-to-moderate **osteomalacia**.
*Laboratory error in measurement of 1,25-dihydroxyvitamin D requiring repeat testing*
- While possible, it is clinically unlikely given that the biochemical pattern correlates perfectly with physiological **secondary hyperparathyroidism**.
- The labs are consistent with **compensatory mechanisms** rather than technical failure; 1,25-dihydroxyvitamin D is often the last parameter to drop in vitamin D deficiency.
*Primary hyperparathyroidism causing increased conversion of 25-hydroxyvitamin D to active form*
- **Primary hyperparathyroidism** is characterized by high serum **calcium**, whereas this patient presents with **hypocalcemia**.
- The elevated PTH here is a reactive **secondary hyperparathyroidism** prompted by low calcium and low vitamin D levels.
*Adequate sun exposure providing sufficient cutaneous vitamin D synthesis independent of oral supplementation*
- Cutaneous synthesis produces **cholecalciferol**, which would still be converted to **25-hydroxyvitamin D** in the liver; if this were sufficient, the 25(OH)D lab value would not be low.
- This patient's **low 25-hydroxyvitamin D** level confirms an overall deficiency in vitamin D stores, regardless of the source (dietary vs. cutaneous).
*Chronic kidney disease causing impaired vitamin D metabolism despite normal creatinine*
- In **Chronic Kidney Disease (CKD)**, the kidneys generally fail to produce **1,25-dihydroxyvitamin D**, resulting in **low** levels of the active form, not normal levels.
- The presence of **pseudofractures** (Looser zones) and low 25(OH)D specifically points toward **osteomalacia** caused by malabsorption rather than renal failure.
Question 5: A 6-month-old infant born prematurely at 28 weeks gestation is brought to the pediatrician for a well-child visit. The infant has been exclusively formula-fed with a standard cow's milk-based formula. Physical examination reveals pallor, irritability, and mild jaundice. Laboratory studies show hemoglobin 8.5 g/dL, elevated indirect bilirubin, and decreased haptoglobin. Peripheral blood smear shows fragmented red blood cells and acanthocytes. The infant's creatine kinase is also elevated. Apply your understanding of neonatal biochemistry to determine the most appropriate initial intervention.
A. Folate supplementation for megaloblastic anemia of prematurity
B. Immediate blood transfusion and investigation for hemoglobinopathy
C. Phototherapy for suspected glucose-6-phosphate dehydrogenase deficiency
D. Supplementation with alpha-tocopherol and monitoring of hemolysis markers (Correct Answer)
E. Intravenous iron supplementation for prematurity-related anemia
Explanation: ***Supplementation with alpha-tocopherol and monitoring of hemolysis markers***
- Preterm infants have limited **alpha-tocopherol (Vitamin E)** stores, making their RBC membranes susceptible to **oxidative stress**, resulting in **hemolytic anemia**.
- The combination of **hemolytic markers** (low haptoglobin, high indirect bilirubin), **acanthocytes**, and elevated **creatine kinase** (muscle involvement) is pathognomonic for **vitamin E deficiency**.
*Immediate blood transfusion and investigation for hemoglobinopathy*
- Hemoglobinopathies like **Sickle Cell** or **Thalassemia** usually present later or with different smear findings like **target cells** or sickling.
- **Transfusion** is reserved for severe, life-threatening anemia, whereas treating the **underlying nutritional deficiency** is the primary initial step here.
*Intravenous iron supplementation for prematurity-related anemia*
- **Anemia of prematurity** is usually normocytic and non-hemolytic; the presence of **fragmented RBCs** points specifically toward **oxidative membrane damage**.
- Providing **iron** without sufficient antioxidants like Vitamin E can actually catalyze **free radical production** and exacerbate hemolysis.
*Phototherapy for suspected glucose-6-phosphate dehydrogenase deficiency*
- While **G6PD deficiency** causes hemolysis, the elevated **creatine kinase** suggests a more systemic antioxidant deficit characteristic of **vitamin E** deficiency.
- **Phototherapy** treats the symptom of jaundice but does not address the underlying **oxidative fragility** of the cell membranes or the muscle damage.
*Folate supplementation for megaloblastic anemia of prematurity*
- **Folate deficiency** results in **macrocytic anemia** with hypersegmented neutrophils, not the fragmented **acanthocytes** seen on this smear.
- It does not explain the presence of **hemolytic markers** like decreased **haptoglobin** or the associated muscle-related elevation of **creatine kinase**.
Question 6: A 28-year-old woman presents with easy bruising and prolonged bleeding after minor cuts. She reports following a strict fat-free diet for weight loss over the past 6 months. Laboratory studies show prolonged prothrombin time (PT) and normal activated partial thromboplastin time (aPTT). Administration of a specific vitamin corrects the PT within hours. However, the patient also complains of night blindness that does not improve with the same vitamin supplementation. Evaluate the most likely explanation for this clinical scenario.
A. The patient has primary hypercoagulable state masked by vitamin supplementation
B. The patient has combined vitamin K and vitamin A deficiency due to fat malabsorption from the restrictive diet (Correct Answer)
C. The bleeding is due to vitamin C deficiency and night blindness is due to thiamine deficiency
D. The patient has vitamin K deficiency only; the night blindness is unrelated and due to retinal disease
E. The patient has isolated vitamin E deficiency causing both coagulopathy and retinal dysfunction
Explanation: ***The patient has combined vitamin K and vitamin A deficiency due to fat malabsorption from the restrictive diet***
- A **strict fat-free diet** leads to the malabsorption of **fat-soluble vitamins** (A, D, E, and K), as these require dietary lipids and bile for micelle formation and absorption.
- **Vitamin K deficiency** causes **prolonged PT** (due to decreased factors II, VII, IX, X), while **Vitamin A deficiency** causes **night blindness** due to the depletion of retinal in the rods.
*The patient has vitamin K deficiency only; the night blindness is unrelated and due to retinal disease*
- It is highly unlikely for these symptoms to be unrelated given the history of a **fat-free diet**, which physiologically impairs the absorption of all **fat-soluble vitamins**.
- The absence of a history of genetic retinal disease or trauma makes **nutritional deficiency** the most probable common etiology for both symptoms.
*The patient has isolated vitamin E deficiency causing both coagulopathy and retinal dysfunction*
- **Vitamin E deficiency** can cause hemolytic anemia and posterior column signs but does not typically cause a **prolonged PT** responsive to vitamin K-like supplementation.
- While severe deficiency can lead to retinopathy, it does not explain the selective **prolonged PT** and normal aPTT pattern seen in early Vitamin K deficiency.
*The bleeding is due to vitamin C deficiency and night blindness is due to thiamine deficiency*
- **Vitamin C** and **Thiamine** are **water-soluble vitamins** and their absorption is not dependent on dietary fat intake.
- **Vitamin C** deficiency (Scurvy) presents with **bleeding gums** and petechiae rather than a corrected PT, and **thiamine** deficiency causes Beriberi or Wernicke-Korsakoff syndrome, not night blindness.
*The patient has primary hypercoagulable state masked by vitamin supplementation*
- A **hypercoagulable state** would typically lead to thrombosis, whereas this patient presents with **easy bruising** and **prolonged bleeding**, indicating a hypocoagulable state.
- **Vitamin K administration** corrects a deficiency-induced coagulopathy; it would not "unmask" a primary genetic hypercoagulable disorder.
Question 7: A 55-year-old woman with Crohn disease on long-term sulfasalazine therapy presents with fatigue and glossitis. Laboratory studies show hemoglobin 10.1 g/dL with MCV 103 fL and elevated homocysteine levels, but normal methylmalonic acid levels. Peripheral smear shows hypersegmented neutrophils. Despite these findings suggesting a specific vitamin deficiency, her neural tube defect screening during a previous pregnancy 25 years ago showed elevated alpha-fetoprotein. Considering her current medication and disease history, which biochemical pathway is most directly impaired?
A. Conversion of tryptophan to niacin via kynureninase
B. Conversion of homocysteine to methionine via methionine synthase
C. Metabolism of branched-chain amino acids via branched-chain ketoacid dehydrogenase
D. Conversion of methylmalonyl-CoA to succinyl-CoA via methylmalonyl-CoA mutase
E. Synthesis of thymidine via thymidylate synthase (Correct Answer)
Explanation: ***Synthesis of thymidine via thymidylate synthase***
- This patient has **folate deficiency** (megaloblastic anemia, high **homocysteine**, and **normal methylmalonic acid**) likely due to **sulfasalazine** use and malabsorption from Crohn's disease.
- The most direct biochemical impairment is the lack of **N5,N10-methylene tetrahydrofolate**, which is the vital methyl donor for **thymidylate synthase** to convert dUMP to dTMP for DNA synthesis.
*Conversion of homocysteine to methionine via methionine synthase*
- While this pathway is indeed impaired (leading to the observed **elevated homocysteine**), it is common to both folate and **Vitamin B12** deficiencies.
- Impaired DNA synthesis through the **thymidylate synthase** pathway is the primary mechanism for the clinical presentation of **megaloblastic anemia** and cellular changes.
*Conversion of methylmalonyl-CoA to succinyl-CoA via methylmalonyl-CoA mutase*
- This reaction requires **Vitamin B12 (cobalamin)** as a cofactor, not folate.
- The laboratory findings specifically show **normal methylmalonic acid** levels, which rules out an impairment in this specific pathway.
*Metabolism of branched-chain amino acids via branched-chain ketoacid dehydrogenase*
- This pathway requires **Thiamine (B1)**, Lipoate, CoA, FAD, and NAD+ as cofactors.
- Deficiency in this enzyme leads to **Maple Syrup Urine Disease**, which is unrelated to **macrocytic anemia** or **sulfasalazine** therapy.
*Conversion of tryptophan to niacin via kynureninase*
- This pathway is dependent on **Vitamin B6 (pyridoxine)** as a cofactor.
- Impairment would typically result in **pellagra-like symptoms** (dermatitis, diarrhea, dementia) rather than **hypersegmented neutrophils** and megaloblastic changes.
Question 8: A 3-year-old child is brought to the clinic by his mother who reports that he refuses to walk and cries when his legs are touched. Physical examination reveals tenderness over the lower extremities, particularly at the metaphyses of long bones. The child has a protruding abdomen and prominent costochondral junctions. His gums are swollen and bleeding. Dietary history reveals that the family follows a restrictive diet excluding fruits and vegetables. Laboratory studies show normal calcium and phosphate levels. What enzyme deficiency best explains this patient's presentation?
A. Alkaline phosphatase causing defective bone mineralization
B. Lysyl hydroxylase leading to defective collagen cross-linking
C. Transglutaminase resulting in decreased fibrin stabilization
E. Gamma-glutamyl carboxylase affecting clotting factor synthesis
Explanation: ***Prolyl hydroxylase causing impaired collagen triple helix formation***
- This child presents with **scurvy** due to **Vitamin C deficiency**, which results in the dysfunction of **prolyl and lysyl hydroxylase** enzymes required for collagen synthesis.
- Vitamin C is essential for the **hydroxylation of proline and lysine** residues; failure to hydroxylate these residues prevents proper **triple helix formation** and leads to fragile blood vessels and weakened connective tissue.
*Lysyl hydroxylase leading to defective collagen cross-linking*
- While Vitamin C is a cofactor for lysyl hydroxylase, the primary structural failure in scurvy is the inability to form the **triple helix**, which precedes the cross-linking stage.
- **Defective cross-linking** is more specifically associated with **Menkes disease** (copper deficiency affecting lysyl oxidase) or certain types of **Ehlers-Danlos syndrome**.
*Gamma-glutamyl carboxylase affecting clotting factor synthesis*
- This enzyme requires **Vitamin K**, and its deficiency would lead to easy bruising and bleeding (neonatal hemorrhage), but not **subperiosteal tenderness** or bone matrix defects.
- Vitamin K deficiency does not explain the **scorbutic rosary** (prominent costochondral junctions) or the specific dietary lack of fruits and vegetables.
*Transglutaminase resulting in decreased fibrin stabilization*
- **Factor XIII** (transglutaminase) is responsible for cross-linking fibrin, and its deficiency leads to **delayed wound healing** and umbilical stump bleeding.
- It does not present with the characteristic **musculoskeletal findings** or the history of a restrictive diet seen in this patient.
*Alkaline phosphatase causing defective bone mineralization*
- Low levels of this enzyme suggest **hypophosphatasia**, while high levels occur in **rickets**; however, scurvy presents with **normal calcium and phosphate** levels.
- Scurvy is a primary defect in the **protein matrix (osteoid)** synthesis, not a defect in the subsequent **mineralization** of that matrix.
Question 9: A 62-year-old man with a history of gastric bypass surgery 5 years ago presents with progressive weakness, paresthesias in his lower extremities, and difficulty with balance. Physical examination reveals decreased vibration and proprioception in the legs, absent ankle reflexes, and a positive Romberg sign. Complete blood count shows hemoglobin 9.2 g/dL with MCV 112 fL. Peripheral blood smear shows hypersegmented neutrophils. What is the underlying biochemical mechanism of his neurological symptoms?
A. Deficient glutathione peroxidase activity causing oxidative damage
B. Impaired methylmalonyl-CoA mutase activity leading to accumulation of toxic metabolites (Correct Answer)
C. Impaired carboxylase enzyme function affecting fatty acid metabolism
D. Defective collagen cross-linking due to reduced lysyl oxidase activity
E. Decreased alpha-ketoglutarate dehydrogenase activity impairing energy production
Explanation: ***Impaired methylmalonyl-CoA mutase activity leading to accumulation of toxic metabolites***
- **Vitamin B12** is a cofactor for **methylmalonyl-CoA mutase**; its deficiency leads to an accumulation of **methylmalonyl-CoA**, which results in the synthesis of **abnormal fatty acids** incorporated into neuronal membranes.
- This biochemical failure causes **subacute combined degeneration** of the spinal cord, specifically affecting the **posterior columns** (vibration/proprioception) and **lateral corticospinal tracts**.
*Defective collagen cross-linking due to reduced lysyl oxidase activity*
- This mechanism describes the pathophysiology of **Menkes disease** (copper deficiency) or **Ehlers-Danlos syndrome**, not megaloblastic anemia.
- **Lysyl oxidase** requires copper as a cofactor, whereas this patient’s symptoms and **hypersegmented neutrophils** point to a vitamin deficiency.
*Decreased alpha-ketoglutarate dehydrogenase activity impairing energy production*
- This mechanism is characteristic of **Vitamin B1 (Thiamine)** deficiency, as alpha-ketoglutarate dehydrogenase is a **thiamine pyrophosphate (TPP)** dependent enzyme.
- Thiamine deficiency typically presents as **Wernicke-Korsakoff syndrome** or **Beriberi**, lacking the **macrocytic anemia** seen here.
*Impaired carboxylase enzyme function affecting fatty acid metabolism*
- This refers to **Biotin (Vitamin B7)** deficiency, which serves as a cofactor for enzymes like **pyruvate carboxylase** and **acetyl-CoA carboxylase**.
- Biotin deficiency presents with **dermatitis**, alopecia, and enteritis, but does not cause **megaloblastic anemia** or dorsal column loss.
*Deficient glutathione peroxidase activity causing oxidative damage*
- This mechanism is associated with **Selenium** deficiency or defects in the **pentose phosphate pathway** (G6PD deficiency) affecting NADPH levels.
- Lack of glutathione protection leads to **hemolytic anemia** (Heinz bodies), rather than the **subacute combined degeneration** of the cord seen in this patient.
Question 10: A 45-year-old chronic alcoholic presents to the emergency department with confusion, ataxia, and ophthalmoplegia. His wife reports he has been drinking heavily for the past 3 months and eating very little. Vital signs show blood pressure 130/85 mmHg, heart rate 98/min, and temperature 37.2°C. Before administering intravenous dextrose for suspected hypoglycemia, which intervention is most appropriate to prevent worsening of his neurological condition?
A. Administer intravenous pyridoxine
B. Administer intravenous thiamine (Correct Answer)
C. Administer intravenous magnesium sulfate
D. Administer intramuscular vitamin B12
E. Administer oral folate supplementation
Explanation: ***Administer intravenous thiamine***
- The patient exhibits the classic triad of **Wernicke encephalopathy** (confusion, ataxia, and ophthalmoplegia), which is caused by a severe deficiency of **thiamine (vitamin B1)**.
- Thiamine must be administered **before glucose** because it is a cofactor for **pyruvate dehydrogenase**; giving glucose first can consume the last thiamine reserves and lead to permanent neurological damage.
*Administer intramuscular vitamin B12*
- **Vitamin B12 deficiency** primarily causes subacute combined degeneration of the spinal cord and megaloblastic anemia, not an acute presentation of ophthalmoplegia and ataxia.
- While alcoholics may have multiple deficiencies, B12 administration does not prevent the acute **metabolic crisis** triggered by glucose loading in thiamine deficiency.
*Administer oral folate supplementation*
- **Folate (vitamin B9) deficiency** is common in chronic alcoholism and leads to **macrocytic anemia**, but it is not associated with the acute triad of Wernicke encephalopathy.
- Oral administration is inappropriate in an **emergency setting** where rapid restoration of cofactors is needed to prevent irreversible brain injury.
*Administer intravenous magnesium sulfate*
- **Magnesium** is a required cofactor for many thiamine-dependent enzymes, and deficiency can cause **thiamine resistance**, but it is not the primary treatment for Wernicke encephalopathy.
- While magnesium should be replaced if low, the most critical intervention to prevent worsening of neurological status before dextrose is **thiamine**.
*Administer intravenous pyridoxine*
- **Pyridoxine (vitamin B6)** deficiency can lead to peripheral neuropathy or sideroblastic anemia, but it does not cause the **acute encephalopathy** seen in this patient.
- Pyridoxine is not involved in the oxidative decarboxylation of glucose metabolism pathways that are compromised in **Wernicke encephalopathy**.
